KARUNA THERAPEUTICS INC's ticker is KRTX and the CUSIP is 48576A100. A total of 257 filers reported holding KARUNA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 1.01 and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $3,580,819 | -23.7% | 21,177 | -2.2% | 0.01% | -16.7% |
Q2 2023 | $4,694,586 | -40.7% | 21,649 | -50.3% | 0.01% | -40.0% |
Q1 2023 | $7,911,329 | -14.1% | 43,555 | -7.1% | 0.01% | -23.1% |
Q4 2022 | $9,207,990 | -14.8% | 46,860 | -2.5% | 0.01% | -18.8% |
Q3 2022 | $10,805,412 | +150.2% | 48,039 | +40.8% | 0.02% | +45.5% |
Q2 2022 | $4,318,000 | +291.5% | 34,127 | +292.4% | 0.01% | +450.0% |
Q1 2022 | $1,103,000 | -3.2% | 8,698 | 0.0% | 0.00% | 0.0% |
Q4 2021 | $1,139,000 | +7.8% | 8,698 | +0.7% | 0.00% | 0.0% |
Q3 2021 | $1,057,000 | +7.3% | 8,640 | 0.0% | 0.00% | 0.0% |
Q2 2021 | $985,000 | +17.8% | 8,640 | +24.3% | 0.00% | 0.0% |
Q1 2021 | $836,000 | +19.6% | 6,950 | +1.0% | 0.00% | +100.0% |
Q4 2020 | $699,000 | +68.8% | 6,884 | +28.6% | 0.00% | 0.0% |
Q3 2020 | $414,000 | -30.7% | 5,354 | 0.0% | 0.00% | 0.0% |
Q2 2020 | $597,000 | +57.1% | 5,354 | +1.6% | 0.00% | 0.0% |
Q1 2020 | $380,000 | – | 5,272 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Pivotal bioVenture Partners Investment Advisor LLC | 782,008 | $142,043,933 | 58.49% |
Nan Fung Group Holdings Ltd | 225,688 | $40,993,968 | 27.90% |
Sofinnova Investments, Inc. | 1,773,124 | $322,070,243 | 20.60% |
Artia Global Partners LP | 88,831 | $16,135,263 | 5.96% |
DAFNA Capital Management LLC | 78,573 | $14,272,000 | 4.28% |
First Light Asset Management, LLC | 243,675 | $44,261,127 | 3.98% |
CATALYST PRIVATE WEALTH, LLC | 21,837 | $3,966,473 | 2.74% |
Sands Capital Ventures, LLC | 58,895 | $10,697,688 | 2.64% |
ARCH Venture Management, LLC | 30,000 | $5,449,200 | 2.63% |
Logos Global Management LP | 100,000 | $18,164,000 | 2.60% |